Alere Inc

Latest Alere Inc News and Updates

  • uploads///ALR ABT acquisition
    Company & Industry Overviews

    A Brief Recap of the Abbott–Alere Deal Developments

    Three months after announcing a $5.8 billion deal in which Abbott Laboratories (ABT) would buy Alere (ALR), Alere rejected Abbott’s $50 million offer to end the deal. On December 7, Abbott sued Alere to terminate the deal.

    By Sarah Collins
  • uploads///Graph

    Does Novartis See Much Potential for Its Surgical Business?

    In 2017, Novartis (NVS) has planned to conduct a review of its Alcon segment to evaluate the business’s growth potential.

    By Margaret Patrick
  • uploads///medical optics
    Company & Industry Overviews

    The Rationale behind Johnson & Johnson’s Acquisition of Abbott Medical Optics

    On September 16, 2016, Johnson & Johnson announced the acquisition of Abbott Medical Optics, a subsidiary of Abbott Laboratories, and its stock fell ~0.3%.

    By Sarah Collins
  • uploads///STJ ABT portfolio

    Rationale for the St. Jude Medical-Abbott Merger Transaction

    Abbott Labs is buying St. Jude Medical for about $30 billion in cash, stock, and assumed debt to become a dominant player in the cardiovascular health space.

    By Brent Nyitray, CFA, MBA
  • © Copyright 2022 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.